A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings

Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Erica Frew, Douglas Roberts, Shelly Barry, Matthew Holden, Amanda Restell Mand, Emily Mitsock, Enqing Tan, Wei Yu, Johan Skog
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5bca0fb6db4f425babdb323db478f1a8
record_format dspace
spelling oai:doaj.org-article:5bca0fb6db4f425babdb323db478f1a82021-11-28T12:19:29ZA SARS-CoV-2 antigen rapid diagnostic test for resource limited settings10.1038/s41598-021-02128-y2045-2322https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a82021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02128-yhttps://doaj.org/toc/2045-2322Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpensive and immediate test methods are required to facilitate local, regional, and national management strategies to re-open world economies. Here we have developed a SARS-CoV-2 antigen test in an inexpensive lateral flow format to generate a chromatographic result identifying the presence of the SARS-CoV-2 antigen, and thus an active infection, within a patient anterior nares swab sample. Our 15-min test requires no equipment or laboratory infrastructure to administer with a limit of detection of 2.0 × 102 TCID50/mL and 87.5% sensitivity, 100% specificity when tested against 40 known positive and 40 known negative patient samples established by a validated RT-qPCR test.Erica FrewDouglas RobertsShelly BarryMatthew HoldenAmanda Restell MandEmily MitsockEnqing TanWei YuJohan SkogNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Erica Frew
Douglas Roberts
Shelly Barry
Matthew Holden
Amanda Restell Mand
Emily Mitsock
Enqing Tan
Wei Yu
Johan Skog
A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
description Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 disease. RT-qPCR has been the primary method of diagnosis; however, the required infrastructure is lacking in many developing countries and the virus has remained a global challenge. More inexpensive and immediate test methods are required to facilitate local, regional, and national management strategies to re-open world economies. Here we have developed a SARS-CoV-2 antigen test in an inexpensive lateral flow format to generate a chromatographic result identifying the presence of the SARS-CoV-2 antigen, and thus an active infection, within a patient anterior nares swab sample. Our 15-min test requires no equipment or laboratory infrastructure to administer with a limit of detection of 2.0 × 102 TCID50/mL and 87.5% sensitivity, 100% specificity when tested against 40 known positive and 40 known negative patient samples established by a validated RT-qPCR test.
format article
author Erica Frew
Douglas Roberts
Shelly Barry
Matthew Holden
Amanda Restell Mand
Emily Mitsock
Enqing Tan
Wei Yu
Johan Skog
author_facet Erica Frew
Douglas Roberts
Shelly Barry
Matthew Holden
Amanda Restell Mand
Emily Mitsock
Enqing Tan
Wei Yu
Johan Skog
author_sort Erica Frew
title A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
title_short A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
title_full A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
title_fullStr A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
title_full_unstemmed A SARS-CoV-2 antigen rapid diagnostic test for resource limited settings
title_sort sars-cov-2 antigen rapid diagnostic test for resource limited settings
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5bca0fb6db4f425babdb323db478f1a8
work_keys_str_mv AT ericafrew asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT douglasroberts asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT shellybarry asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT matthewholden asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT amandarestellmand asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT emilymitsock asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT enqingtan asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT weiyu asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT johanskog asarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT ericafrew sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT douglasroberts sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT shellybarry sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT matthewholden sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT amandarestellmand sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT emilymitsock sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT enqingtan sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT weiyu sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
AT johanskog sarscov2antigenrapiddiagnostictestforresourcelimitedsettings
_version_ 1718408078955642880